Wednesday, January 29, 2020

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.

from Moneycontrol Business News https://ift.tt/2RCYxBJ

No comments:

Post a Comment

Global Market Today: Asian stocks hit record highs, oil heads for weekly loss

Asian stocks reached a record high, fueled by optimism that the reopening of the Strait of Hormuz will normalize oil flows and ease inflatio...